Search

everythinglearnresearchcommunity

for

Search:↓

Having asthma, atopic dermatitis, or Hashimoto's thyroiditis increases the risk of severe and long-lasting alopecia areata.

Autoimmune polyglandular syndrome can cause temporary brain issues that may improve on their own.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

No significant link between hair loss and iron or thyroid levels was found, but checking for deficiencies might still be useful.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Tofacitinib is an effective and safe treatment for alopecia areata.

Hypothyroidism-related skin issues in dogs are most common in older male Labradors, causing hair loss, slow heart rate, and obesity.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

Iodotherapy for thyroid cancer can cause dry mouth, taste loss, infections, and hair loss, so report side effects to doctors.

Confirm testosterone levels with advanced tests to avoid unnecessary procedures.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Managing multiple autoimmune diseases in one patient is very challenging.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

T-cell patterns in skin help distinguish alopecia areata from androgenetic alopecia.

Skin changes like dryness and hair loss can signal hypothyroidism before tests confirm it.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

A dog with a pituitary tumor developed tertiary hypothyroidism, improved with treatment, but was later euthanized due to neurological issues.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

The man had pretibial myxedema and hyperthyroidism, causing skin changes and thyroid issues.

Botulinum toxin type A injections are not effective for severe alopecia areata.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.